Navigation Links
Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund
Date:10/3/2007

te attractive returns to our investors."

Notes for Editors:

Background

Gilde Healthcare Partners currently has over EUR 275 million (USD 390 million) under management and is actively looking to lead new investments in therapeutics, diagnostics, medical devices and enabling technologies. Gilde Healthcare Partners is a successful builder of healthcare businesses across Europe. By investing in companies with clear achievable business models, Gilde Healthcare Partners has used its financial resources and network to create significant value for both its investors and the entrepreneurs it backs.

Founded in 2000, Gilde Healthcare Partners is headquartered in Utrecht, The Netherlands with representatives in London and Madrid. Companies that Gilde Healthcare Partners has pro-actively supported span all aspects of healthcare and include Ablynx (Belgium), Agendia (Netherlands), AMT (Netherlands), Chroma Therapeutics (UK), Glycart (Switzerland), Innate Pharma (France) and Symphogen (Denmark). For a full list of Gilde's portfolio companies please visit the website.

http://www.gildehealthcare.nl

Gilde Healthcare II is supported by the European Communities Growth and Employment Initiative, MAP - ETF Start up Facility


'/>"/>
SOURCE Gilde Healthcare Partners
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Web-based reporting credited with states top healthcare ranking
2. Visions: Preizler offers insurers perspective on healthcare IT
3. Federal bill would set healthcare IT standards
4. IRS ruling could speed healthcare technology adoption
5. Bill would provide federal aid for healthcare IT
6. DHC 2007: Hayden says technology creates magic moment for healthcare delivery
7. Digital Healthcare Conference 2007: Mounting obstacles for health IT
8. Georgia healthcare system to install GEs radio frequency ID
9. GE Healthcare leads compact ultrasound market
10. CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare
11. Merge Healthcare suffers $258M loss in `06

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...KJAVIK,Iceland,November24/PRNewswire-FirstCall/--d...atithasreceivednoticefrom,theNasdaqStockMarketthat...ofNovember30,2009andaForm25-NSEwillbefiledwiththe,...ODE,scommonstock,fromlistingonNasdaq,unlessthecomp...anel.Thecompanyhasfiledsuchanappeal,which,willstay...
(Date:11/24/2009)... Health care employment grew by 29...ly one to show consistent growth during the U.S. r... remain in trouble, and health systems are coming ..., instead of just administrators. , ...e employment continued growing in October despite ...
(Date:11/24/2009)...NGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsI...asallowedthepatentapplicationfor,itsnano-particleo...ahighlyefficientapproachtoincorporatepeptidesor,pr...liveryofdrugs,otherwiseadministeredasinjections.NO...omanymacromoleculardrugssuchasinsulin,interferon,...
(Date:11/24/2009)...NGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyanno...FDA)hasapprovedthe,investigationalnewdrugapplicati...iveinsulinformulationtotreatdiabetes.ThisIND,appro...udy. , Diabetesisadisordercharacteristicofhig...diabetesoftenresultinseveremicro-and,macro-vascula...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...ds, March 10 Two clinical,psychologists associate...lland, Jaap Hollander and Jeffrey Wijnberg, have d...Mentor." MindMentor is an online computer,program .... It has the,unique quality, as compared with othe...no live human intervention and being completely au...
...ams Up with YWCA & Roche to Educate Patients on, ...Cancer and a Career -, NEW YORK, March 10 In rec...cer and Careers, a non-profit program,founded by C...launching a,seminar which offers guidance for the ... on how to return to work after a cancer diagnosis...
...nd, Jr., J.D., joins BrainCells, Board of ... 10 BrainCells Inc. (BCI), a,biopharmaceutical co...y and,develop compounds that promote the growth of...system (CNS) diseases, announced today that it has...ries B financing. New,investor MedImmune Ventures ...
Other Biology Technology:Robot Psychologist: A New Era in Mental Health Services With MindMentor 2First-Ever 'Cancer and Careers' Seminar Debuts in Orange County 2First-Ever 'Cancer and Careers' Seminar Debuts in Orange County 3BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing 2
(Date:11/23/2009)...ence that the "synergistic" effect of early-life e...and indoor endotoxin causes more harm to developin... Environmental health scientists at the Universit...n that children exposed to both high levels of tra... early life are six times more likely to experienc...
(Date:11/23/2009)...day matters to forest trees dealing with drought, ...am led by Professor Malcolm Campbell, University o...h and colleagues in the department of cell and sys...alizing on their previous work to decode the genom...ow poplar trees use their 45,000 genes to respond ...
(Date:11/23/2009)...hat a common oral bacterium may exacerbate autoimm... "Unique Lipids from a Common Human Bacterium Repr...cing Autoimmunity," appears in the December 2009 i...ultiple sclerosis (MS), a disease where the immune... nearly 1 in 700 people in the United States. Pat...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report 53682 1Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report 53682 2Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report 53682 3100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 1100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 2100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 3Abnormal Brain Circuits May Prevent Movement Disorder 53678 1Abnormal Brain Circuits May Prevent Movement Disorder 53678 2Abnormal Brain Circuits May Prevent Movement Disorder 53678 3Abnormal Brain Circuits May Prevent Movement Disorder 53678 4
...05 flu season was at least as severe as the 2003-2...m Solucient, a leading provider of healthcare info...st recent flu season from being even worse. , A fl...sions for community-acquired pneumonia (CAP), one ...ient analyzed CAP discharge data from October 2002...
...to a new treatment for nerve damage caused by diab...tients, say experts. , The treatment might also r...f early effects on nerve protection and regenerati...tes is the major cause of non-traumatic lower limb...ists at The University of Manchester, working with...
...ng with Arabidopsis, a fast-growing cousin of the ... of North Carolina at Chapel Hill got a big surpri...ks from disease organisms such as bacteria and vir...r experiments showed that at least three different...of war or teeter totter-fashion to keep plant defe...
Other Biology News:Diabetic nerve therapy shows 'striking' results 2FDA approves more generic AIDS drugs 2FDA approves more generic AIDS drugs 3
Canine IFN-gamma ELISA Kit from R&D Systems
Non-Protein Peroxidase Stabilizer from BioFX Laboratories, Inc.
... Lysate contains the cellular components necessary...ds, initiation, elongation and termination factors...se. Untreated Lysate is used primarily for the iso...ce of endogenous globin mRNA. Untreated Lysate is ...
MagCellect Magnet from R&D Systems
Biology Products: